We run phase II–IV clinical trials across nine owned research sites, under one quality system, one set of standards, one accountable team.
Care that outlasts the protocol
Every volunteer is seen by a named investigator, given unhurried time, and supported long after the final study visit is signed off.
Sites that deliver on the plan
Median 11 days from site activation to first participant screened, with a 92% retention rate across our last forty completed studies.
JustClinicals is an integrated research organisation. We own and centrally manage our investigator sites rather than brokering them, which means sponsors get one contract, one quality system, and one team accountable for delivery from feasibility through to database lock.
Our investigators are practising clinicians. Our coordinators are retained, not rotated. And our participants are treated as collaborators in the research rather than a recruitment number — because that is, in the end, what determines whether a study finishes on time and with data anyone can trust.
We work with global pharmaceutical companies, biotechs and CROs across ten therapeutic areas, running phase II to phase IV interventional studies alongside observational and registry work.
01
Care sits at the centre of how we run studies. You will be given time to ask questions, a named contact for the whole trial, and complete freedom to withdraw at any point without affecting your usual NHS or physician care.
For participants
02
A clinical trial is a carefully designed study that answers a specific question about an investigational treatment — whether it works, how safely, and for whom. Every trial follows a protocol reviewed by an independent ethics committee before a single participant is seen.
How trials work
03
Current therapies do not work well for everyone. If you live with moderate or severe symptoms in one of our therapeutic areas, we would like to hear from you — registering takes a few minutes and commits you to nothing.
Register interestMulti-site studies fail on coordination far more often than they fail on science. Our model removes the seams.
Figures are refreshed quarterly and drawn from our own CTMS. We are happy to walk sponsors through the underlying data during feasibility — including the studies that did not go to plan.
Research only works if communities trust it and the next generation of investigators is trained to run it properly.
We run open evenings, school science sessions and faith-group briefings in every city where we operate. Under-representation in clinical research is not a mystery — it is a consequence of never being asked. We are trying to fix our part of that.
Learn more
Our Milton Keynes site is an approved training location for the Pharmaceutical Medicine Specialty Training programme. Doctors completing the programme are entered on the specialist register in pharmaceutical medicine.
Training pathways
Twelve-month paid apprenticeships for people entering clinical research without a traditional route in, plus shorter observational attachments for medical students and allied health professionals.
See the programmes
Our ninth location adds spirometry, methacholine challenge and overnight observation capacity.
Three findings, none critical — and the process changes we made in the eight weeks after.
Two years of community work, and the recruitment demographics that shifted because of it.
Volunteers learn more about their own condition, gain early access to investigational treatments, and move medicine forward for everyone who comes next. Every visit is supervised by a qualified investigator, and you can withdraw at any point.
